Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

January 13, 2021

Biotech Arvinas adds to Science Park footprint

PHOTO | File image Science Park is home to a number of biotech companies, including Arvinas Inc., Cybrexa Therapeutics and Artificial Cell Technologies.

New Haven biotechnology company Arvinas Inc. is expanding its footprint at Yale’s Science Park by 10,000 square feet to make room for a wave of new hires.

Arvinas, which is developing treatments for prostate and breast cancer, has extended its main lease at 5 Science Park, as well as another at 4 Science Park, through 2024, according to a Securities and Exchange Commission filing and company officials.

The biotech founded by renowned Yale scientist Dr. Craig Crews has been steadily growing its physical presence since launching in a 9,500-square foot space at Science Park in 2013. It now takes up about 63,500 square feet in the two buildings, according to regulatory filings.

CEO John Houston told New Haven Biz that the latest expansion will allow for additional lab space to meet the needs of the company’s growing headcount.

Arvinas grew its team by 50 employees in 2020 and expects to employ 250 by the end of this year.

“We anticipate hiring approximately 75 more people in 2021. Arvinas has a busy and exciting year of growth ahead,” Houston said. 

Arvinas is the largest tenant at 5 Science Park, taking up around 60,000 of the building’s 100,000 square feet. It is acquiring the additional space from a tenant that is relocating.

Houston said the company has made significant investments within Science Park and just completed a renovation of office space to lab space. 

The landlord for the buildings is Science Park Development Corp., a non-profit established by Yale, the city of New Haven and Olin Corp. Real estate firm Colliers International handles leasing for the property. 

Contact Natalie Missakian at news@newhavenbiz.com

Sign up for Enews

0 Comments

Order a PDF